Non‐bacterial cystitis with increased expression of programmed death‐ligand 1 in the urothelium: An unusual immune‐related adverse event during treatment with pembrolizumab for lung adenocarcinoma

INTRODUCTION: Immune checkpoint inhibitors are now a standard therapeutic option for lung adenocarcinoma. However, Immune checkpoint inhibitors often induce various immune‐related adverse events. CASE PRESENTATION: The patient was a 78‐year‐old woman with lung adenocarcinoma who had a partial respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueki, Yohei, Matsuki, Masahiro, Kubo, Terufumi, Morita, Rena, Hirohashi, Yoshihiko, Sato, Syunsuke, Horibe, Ryota, Matsuo, Kazuhiko, Tsukahara, Tomohide, Kanaseki, Takayuki, Takakuwa, Yasunari, Satoh, Masaaki, Itoh, Naoki, Torigoe, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609190/
https://www.ncbi.nlm.nih.gov/pubmed/33163921
http://dx.doi.org/10.1002/iju5.12211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609190/
https://www.ncbi.nlm.nih.gov/pubmed/33163921
http://dx.doi.org/10.1002/iju5.12211

Ejemplares similares